Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy
Studying Congenital muscular dystrophy
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- Nationwide Children's Hospital
- Principal Investigator
- Anne M Connolly, MDNationwide Childrens Hospital
- Enrollment
- 44 enrolled
- Eligibility
- 5 years · All sexes
- Timeline
- 2025 – 2028
Study locations (14)
- University of California, Los Angeles, Los Angeles, California, United States
- Stanford University, Stanford, California, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- University of Iowa Stead Family Children's Hospital, Iowa City, Iowa, United States
- National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
- University of Minnesota, Saint Paul, Minnesota, United States
- Washington University in St. Louis, St Louis, Missouri, United States
- University of Rochester, Rochester, New York, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- Nationwide Children's Hospital, Columbus, Ohio, United States
- Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
- University of Texas Southwestern, Dallas, Texas, United States
- University of Utah, Salt Lake City, Utah, United States
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS) · Ann & Robert H Lurie Children's Hospital of Chicago · Children's Hospital Medical Center, Cincinnati · University of Iowa · Washington University School of Medicine · Stanford University · University of Utah · University of Rochester · University of Pittsburgh · University of Texas, Southwestern Medical Center at Dallas · University of Minnesota · University of California, Los Angeles · Boston Children's Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06503367 on ClinicalTrials.govOther trials for Congenital muscular dystrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07125040Characterization of the Natural History of LAMA2-RD and Identification of Novel Disease BiomarkersUniversità Vita-Salute San Raffaele
- RECRUITINGNCT06354790Natural History Study of Children With LAMA2-related DystrophiesInstitut de Myologie, France
- RECRUITINGNCT07505342Remote Assessments and Genetic Determinants of Myotonic DystrophyUniversity of Rochester
- RECRUITINGNCT06924125Spanish Natural History Study for LAMA2 Muscular DystrophyHospital Universitari Vall d'Hebron Research Institute
- ACTIVE NOT RECRUITINGNANCT04038138Clinical Trial Readiness Network FSHD France: Prospective 24 Months MRI StudyCentre Hospitalier Universitaire de Nice
- RECRUITINGNCT01403402Congenital Muscle Disease Study of Patient and Family Reported Medical InformationCure CMD
- RECRUITINGNCT00138931Genetics of Cardiovascular and Neuromuscular DiseaseUniversity of Chicago